2014
DOI: 10.1016/j.mvr.2014.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the Spontaneously Hypertensive Rat

Abstract: Metabolic disease is accompanied by a range of cellular defects (“comorbidities”) whose origin is uncertain. To investigate this pathophysiological phenomenon we used the Spontaneously Hypertensive Rat (SHR), which besides an elevated arterial blood pressure also has many other comorbidities, including a defective glucose and lipid metabolism. We have shown that this model of metabolic disease has elevated plasma matrix metalloproteinase (MMP) activity, which cleaves the extracellular domain of membrane recept… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
9
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 47 publications
1
9
0
Order By: Relevance
“…Notably, chronic treatment with MMP inhibitors reduced receptor cleavage, blood pressure and insulin resistance in SHRs and increased capillary density, which supports the importance of increased MMP activity in the pathophysiology of hypertension and its comorbidities [19,20]. A similar mechanism of proteolytic receptor cleavage is observed in other comorbidities, such as deficiencies in immune function (e.g., leukocyte adhesion), leukocyte mechanotransduction, macrophage functions and cleavage of the glycocalyx in SHRs [26][27][28][29][30].…”
Section: Introductionsupporting
confidence: 55%
“…Notably, chronic treatment with MMP inhibitors reduced receptor cleavage, blood pressure and insulin resistance in SHRs and increased capillary density, which supports the importance of increased MMP activity in the pathophysiology of hypertension and its comorbidities [19,20]. A similar mechanism of proteolytic receptor cleavage is observed in other comorbidities, such as deficiencies in immune function (e.g., leukocyte adhesion), leukocyte mechanotransduction, macrophage functions and cleavage of the glycocalyx in SHRs [26][27][28][29][30].…”
Section: Introductionsupporting
confidence: 55%
“…For example, an inactivated form of CD36, solCD36, has been identified in both murine and human plasma after MI, implicating a natural mechanism of CD36 inactivation after infarction (59). The proteases matrix metalloproteinase 9 and ADAM17 have both been implicated in the cleavage of the CD36 ectodomain from the surface of macrophages (24,59,60). The soluble remnants of these cleaved products can function as decoy receptors, inhibiting interaction between surface receptors and their dead cellular targets (61).…”
Section: Discussionmentioning
confidence: 99%
“…Besides elevated white cell count, indices of inflammation and high levels of oxygen free radicals [36], this rat strain exhibits elevated levels of protease activity in plasma, including MMP-2, MMP-9 (gelatinase A and B), MMP-8, and MMP-7 (matrilysin) [35,37]. While the elevations of plasma MMP activity are modest (about 10 and 25% above the low pressure control strain) they are permanently elevated and accompanied by reduced levels of tissue inhibitor of metalloproteases 1 (TIMP-1,2) [38]. The enhanced MMP activity is accompanied by elevated MMP protein levels, as detected with immunohistochemistry [35].…”
Section: Proteolytic Receptor Cleavage and Co-morbidities In The Smentioning
confidence: 99%
“…If the SHR is chronically treated with MMP inhibitors (e.g. doxycycline at a sub-antibiotic dose level, CGS27023A), its plasma and endothelial MMP activity is reduced to levels of the normotensive WKY rats, its elevated blood pressure is normalized and its β 2 adrenergic receptor population is restored [35,38]. …”
Section: Proteolytic Receptor Cleavage and Co-morbidities In The Smentioning
confidence: 99%
See 1 more Smart Citation